Arrowstreet Capital, Limited Partnership Arcturus Therapeutics Holdings Inc. Put Options Transaction History
Arrowstreet Capital, Limited Partnership
- $108 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARCT
# of Institutions
196Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$101 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$58.9 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$42.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$36.3 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$29.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $571M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...